NCT06044857View on ClinicalTrials.gov

PSMA PET Response Guided SabR in High Risk Pca

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 7, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Prostate Adenocarcinoma
Interventions
DRUG

68-Ga PSMA11

Will be injected/assessed in line with its FDA label.

Trial Locations (2)

75239

RECRUITING

University of Texas Southwestern Medical Center, Dallas

75390

NOT_YET_RECRUITING

UT Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

Once Upon a Time Foundation

OTHER

collaborator

Telix Pharmaceuticals (Innovations) Pty Limited

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER